← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 21, 2022Last known activity
Feb 10, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 5 trials)
Phase 2 (7 own, 0 via acquisition)
Recent trials (13)
- NCT06798415Lead sponsorPhase 2Feb 10, 2025
- NCT06798415Sponsor investigatorPhase 2Feb 10, 2025
- NCT06797544Sponsor investigatorPhase 2Feb 9, 2025
- NCT06797544Lead sponsorPhase 2Feb 9, 2025
- NCT06798402Lead sponsorPhase 2Feb 7, 2025
- NCT06798402Sponsor investigatorPhase 2Feb 7, 2025
- NCT06007430OfficialPhase 2Mar 1, 2023
- NCT06007430Lead sponsorPhase 2Mar 1, 2023
- NCT06007430Reponsible party - principal investigatorPhase 2Mar 1, 2023
- NCT06007430Study chairPhase 2Mar 1, 2023
- NCT06007430Sponsor investigatorPhase 2Mar 1, 2023
- NCT05981742Study chairPhase 2Sep 21, 2022
- NCT05981742OfficialPhase 2Sep 21, 2022
Details
- Last known activity
- Feb 10, 2025